SIGMA LABS, INC.|4Jul 6, 7:08 PM ET

Brunsberg Jacob 4

4 · SIGMA LABS, INC. · Filed Jul 6, 2022

Form 4

Period: 2022-07-01

Director

Transactions

Award
Stock Option (right to buy)
2022-07-01+49,800→ 49,800 total
Exercise: $2.50Exp: 2027-07-01→ Common Stock (49,800 underlying)
Award
Stock Appreciation Right
2022-07-01+194,940→ 194,940 total
Exercise: $2.50Exp: 2027-07-01→ Common Stock (194,940 underlying)
Award
Stock Appreciation Right
2022-07-01+121,298→ 121,298 total
Exercise: $1.30Exp: 2027-07-01→ Common Stock (121,298 underlying)

Footnotes (3)

[F1]The stock option vests, as follows: (i) 12,450 shares subject to the option vested on the date of grant, and (ii) the remaining 37,350 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.
[F2]The stock appreciation right ("SAR") is payable in cash only, and vests on March 15, 2025, subject to the Reporting Person being in the continuous employ of the Issuer on the vesting date.
[F3]The SAR is payable in cash only and vests as follows: (i) 25% of the SAR vested on the date of grant, and (ii) the balance of the SAR will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.

Documents

1 file